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Abstract
Apigenin, a dietary flavonoid, is reported to have several therapeutic effects in different diseases including cancer. Toxicity
of Apigenin is however, least explored, and reports are scanty in literature. This warrants dose-specific evaluation of toxicity
in vivo. In the present study, Apigenin was administered intraperitoneally to Swiss mice at doses of 25, 50, 100 and 200 mg/
kg. Serum levels of alanine amino transferase (ALT), aspartate amino transferase (AST) and alkaline phosphatase (ALP) were
measured along with the examination of liver histology, reactive oxygen species (ROS) in blood, lipid peroxidation (LPO),
glutathione level, superoxide dismutase activity, catalase activity, glutathione S-transferase activity and gene expression in
liver tissue. Increase in ALT, AST, ALP, ROS, ratio of oxidized to reduced glutathione (GSSG/GSH) and LPO, altered enzyme
activities along with damaged histoarchitecture in the liver of 100 or 200 mg/kg Apigenin treated animals were found.
Microarray analysis revealed the differential expression of genes that correspond to different biologically relevant pathways
including oxidative stress and apoptosis. In conclusion, these results suggested the oxidative stress induced liver damage
which may be due to the regulation of multiple genes by Apigenin at higher doses in Swiss mice.
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Introduction
Apigenin (49, 5, 7-trihydroxyflavone) has been shown to possess
diverse therapeutic potentials [1]. It improves cancer cell response
to chemotherapy [2] and prevents tumourogenic activities by
inhibiting protein kinase, MAP Kinase or chronically activates
PI3K-Akt mediated nuclear factor-kappa-B [3]. Apigenin modu-
lates immune cells functioning, maintains immune cells in
inflammation, autoimmunity or lymphoproliferation [3] and
inhibits auto antigen-presenting cells necessary for activation and
expansion of auto reactive Th1 and Th17 cells and B cells in lupus
[4]. Vasorelaxing and anti-platelet activities of Apigenin have also
been demonstrated [5]. Recently, Apigenin has drawn attention of
Scientists for its use in therapeutics [6]. However, few reports
demonstrated that Apigenin produces phenoxyl radicals [7] or
reactive oxygen species [8,9] and induces cytotoxicity [10] or
clastogenicity [11] in different in vitro models. Chemical Selection
Working Group of FDA, USA (2000) recommends developmental
toxicity and chromosomal aberration assays for Apigenin. This
study explored its toxicity on mice liver following single
intraperitoneal exposure.
Materials and Methods
Animals and drug administration
10–12 weeks old male Swiss mice, weighing 25–30 g were
obtained from Laboratory Animal Division of CDRI following
Institutional Animals Ethics Committee clearance (114/07/
Toxicol./IAEC) and randomly allocated to the following groups
containing eight animals each.
Group I: Vehicle (100 ml DMSO) controls
Group II: 25 mg/kg Apigenin
Group III: 50 mg/kg Apigenin
Group IV: 100 mg/kg Apigenin
Group V: 200 mg/kg Apigenin
Animals were treated with Apigenin once and sacrificed 24 hrs
after the treatment. Animals were maintained in optimal conditions
of temperature (2562uC) and 12 hrs light/dark cycles and fed with
standard pelleted diet and water ad libitum. Animal ethics guidelines
were followed in all animal procedures. Apigenin was administered
intraperitoneally as was done in the previous studies [4,6].
Blood collection, serum biochemistry and ROS estimation
At autopsy blood was withdrawn from each animal by cardiac
puncture and allowed to stand undisturbed for 30 min. Serum was
separated and levels ofALT,ASTandALPwereestimated usingan
automated biochemical analyzer (Beckman Coulter, USA). Intra-
cellular ROS in peripheral blood mononuclear cells (PBMC) were
analyzed using fluorescent probe 29,7 9-dichlorofluorescein-diace-
tate, a non-fluorescent compound under normal condition, which is
converted into highly fluorescent dichlorofluorescein (DCF) by
cellular peroxides. Cell-associated fluorescence was monitored on
fluorescence activated cell sorter (Beckman Coulter, USA).
Liver tissue biochemistry
Liver tissue homogenate was used for antioxidant enzymatic
assays. Malondialdehyde (MDA) concentration (a measure of
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(superoxide dismutase, catalase, glutathione peroxidase, glutathi-
one S-transferase) were estimated using standard tests [12–16].
GSH and GSSG contents were estimated following the instruction
of Glutathione Assay Kit (BioVision, CA, USA). Total protein
content was estimated according to Lowry et al. [17] using Bovine
Serum Albumin as a standard.
Liver histology
Liver tissue was fixed in 10% buffered formalin for histological
investigations. Fixed liver tissues were washed overnight, dehy-
drated through graded alcohols and embedded in paraffin wax.
Serial sections of about 5 mm thickness were stained with
hematoxylin and eosin (H&E) for histological examinations.
RNA isolation, Microarray, Clustering and GenMAPP analysis
Total RNA was isolated from 50 mg of frozen liver and
quantified by spectrophotometer and formaldehyde gel electro-
phoresis. RNA samples with approximately 2:1 ratio of 28 S:18 S
rRNA and 260/280 values$1.8 were used for gene expression
analysis. The methodology of microarray experiments was
according to Noel et al. [18]. 22.4 k mouse arrays (http://www.
microarrays.ca) containing 23041 unique probes were used. Raw
intensity data was analyzed with Avadis Express version 4.3
(Strand life Sciences, India) and the background corrected
intensities were LOWESS normalized (Cy5 against Cy3) to obtain
log (base 2) ratios. Statistically significant difference between
controls and Apigenin treated mice was deduced with two sample
t-test and probes with p,0.05 and 2-fold differential expression at
25, 50, 100 mg/kg doses were identified. Raw and log trans-
formed data (series accession no. GSE 12716) has been submitted
to Gene Expression Omnibus database (www.ncbi.nlm.nih.gov/
geo/) and conforms to MIAME guidelines developed by micro-
array gene expression data (MGED) society. Clustering techniques
have been applied for the identification of patterns in gene-
expression. Intensity values of duplicate spots were averaged in
order to get a single mean value to perform k-means clustering
with MeV version 3.1 [TM4, The Institute of Genomic Research].
Each expression cluster was further clustered hierarchically with
Euclidean distance matrix and average linkage to identify gene
with similar expression patterns. Gene expression data of 25, 50,
100 mg/kg doses were separately listed to make a representative
gene-expression dataset for identifying affected pathways using
GenMAPP version 2.1. Moreover, GenMAPP gene expression
dataset file (.gex) was exported to MAPPFinder to calculate the
percentage of genes with significant expression change, statistical
score for each Gene Ontology (GO) term and Z score.
Quantitative real time PCR analysis
Real-time PCR was performed according to the supplier
protocol (Invitrogen, California, USA). Reactions were run in
Light Cycler 480 system using forward and reverse primers
(Table 1 and Table S1) and analyzed by LightCyclerH 480
Software release 1.5.0. Samples were pooled group wise and
experiments were carried out in triplicates. b-actin was used as an
internal control. Melting curve analysis was performed for each
primer pair and relative change in mRNA level between control
and treated groups were calculated by using 2
2DDCT method.
Western blot analysis
Proteinswere isolated from liver tissue using themodifiedprotocol
of Ghribi et al., 2001 [19]. Tissues from control and various
treatment groups were homogenized with 5–10 volumes of lysis
buffer (200 mM HEPES, 10 mM KCl, 1.5 mM MgCl2,1m M
EDTA, 1 mM EGTA, 1 mM DTT, 2 mM PMSF, 16 Protease
inhibitor cocktail). Cellular debris were spun down at 20,0006gf o r
30 min in 4uC and supernatants were used as whole protein extract.
Isolated proteins were quantified using Bradford reagent. 50 mg
protein from each sample was separated on 15% SDS-PAGE and
transferred on to a nitrocellulose membrane using a semi-dry electro
blotting apparatus (GE Healthcare, UK). Transfer was examined by
Ponceau S stain and washed with triple distilled water until the stain
disappeared. Membrane was blocked overnight in 5% Non-Fat
dried milk at 4uC. Membrane was washed with 0.1% PBST and
probed with primary antibodies (Actin, SOD1 and Hsp70). After
primary antibody incubation further washing was done in 0.1%
PBST. Membrane was incubated in HRP conjugated secondary
antibody and washed again. Enhanced chemi-luminescent detection
system (GE Healthcare, UK) was used to develop the blots. Blots
were further used for densitometric analysis and normalization.
Statistical analysis
Data were expressed as mean6standard error of the means
wherever required. Group means were compared by one-way
analysis of variance (ANOVA) followed by Newman-Keuls
Multiple Comparison Test. p,0.05 was considered significant.
Results
Serum ALT, AST and ALP
Serum ALT, AST and ALP were unaltered in 25 or 50 mg/kg
dose groups as compared to control. A significant increase in
serum ALT (100 mg/kg; p,0.01 and 200 mg/kg; p,0.05), AST
(100 and 200 mg/kg; p,0.01) and ALP (100 and 200 mg/kg;
p,0.05) was observed in animals belonging to the higher dose
groups (Figures 1 A–C).
ROS generation
No significant DCF peak shift was observed in 25 mg/kg
Apigenin treated group. The oxidized dichlorofluorescein (DCF)
peak shifts were 2.24 (p,0.05), 5.76 and 6.56 (p,0.001) fold in 50,
100 and 200 mg/kg dose groups respectively as compared to
controls (Figure 2 and Figure S1).
Table 1. List of primers used in Quantitative Real-time
polymerase chain reaction.
Gene Forward primer (59-39) Reverse primer (59-39)
Actb GGCTGTATTCCCCTCCATCG CCAGTTGGTAACAATGCCATGT
Sod1 TTTTTGCGCGGTCCTTTCCTG GGTTCACCGCTTGCCTTCTGCT
Cat AGCGACCAGATGAAGCAGTG TCCGCTCTCTGTCAAAGTGTG
Gpx1 ATGTCGCGTCTCTCTGAGG CCGAACTGATTGCACGGGAA
Gsta4 GCTGCGGCTGGAGTGGAGTTT GGATGGCCCTGGTCTGTGTCA
Hsc70 CCGATGAAGCTGTTGCCTATGGT GTGTCTGCTTGGTGGGGATGGT
Neo1 CATTGTGGTCCGAGGTTATGC GGCACTGGAGTGATGGAGC
Zfp110 GCACTGGAAAGAGGAAAGGCA CTGCTCAGAACCCTGTTGCT
Erp29 GGGCAGTTAAGGTTGGAGCC AGGATCTTCCCCATGATCTTCA
Idh3a TGGGTGTCCAAGGTCTCTC CTCCCACTGAATAGGTGCTTTG
Duox1 CCTGGTTGGGACACTGGCTTCTT GTGTCGGGGGTTAGGCAGGTAGG
Clca1 AGCCCTCATAGAAGCTGAACA CGCACTTTTAGGCTGTATCTACC
Note: List of other primers used in Quantitative Real-time PCR is given in Table
S1.
doi:10.1371/journal.pone.0031964.t001
Apigenin Induces Hepatotoxicity
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31964MDA concentration
MDA concentration in the liver of 25 and 50 mg/kg groups was
unaltered. Significant increase in MDA concentration was found
in 200 mg/kg (p,0.05) group (Figure 3-A). An increase in MDA
concentration was found in 100 mg/kg Apigenin treated animals,
which was statistically non-significant as compared to controls.
GSSG and GSH ratio
A trend of increase in GSSG/GSH ratio was found along the
group (25 mg/kg to 200 mg/kg) of Apigenin and it was
significantly increased in 200 mg/kg group (p,0.05; Figure 3-
B). GSH in liver tissue of 200 mg/kg group was significantly
decreased (p,0.05) but not in other groups (25, 50 or 100 mg/kg)
(Figure S2). A trend of dose dependent increase in GSSG was
observed along the groups (Figure S3).
SOD activity and expression
SOD activity and mRNA level were unaltered in the lower
treatment groups of Apigenin (25 and 50 mg/kg) as compared to
controls. Higher doses of Apigenin significantly reduced the
activity (100 mg/kg; p,0.05 and 200 mg/kg; p,0.01; Figure 3-
C) and expression of SOD measured at transcript (Figure 4-A) and
protein (Figures 5-A and B) level as compared to controls.
Figure 2. Mean fluorescence intensity of dichlorofluorescein
(DCF). Intracellular ROS in peripheral blood mononuclear cells (PBMC)
were analyzed in Apigenin treated animals at different doses (Control,
25, 50, 100 and 200 mg/kg) using fluorescent probe 29,7 9-dichloro-
fluorescein-diacetate. The asterisks indicate significance of differences
(*-p,0.05; ** -p,0.01; ***-p,0.001) in comparison to control.
doi:10.1371/journal.pone.0031964.g002
Figure 1. Levels of serum biomarkers of hepatotoxicity. (A) Alanine amino transferase (ALT), (B) Aspartate amino transferase (AST), and (C)
Alkaline phosphatase (ALP) levels were estimated in serum following the administration of Apigenin at different doses (Control, 25, 50, 100 and
200 mg/kg). The asterisks indicate significance of differences (*-p,0.05; **-p,0.01; ***-p,0.001) in comparison to control.
doi:10.1371/journal.pone.0031964.g001
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CAT, GPx activities and mRNA level did not change in
lower treatment groups (25 and 50 mg/kg) of Apigenin as
compared to control. In 100 mg/kg Apigenin treated group,
increase in CAT (p,0.05) and GPx (not significant) mRNA
level was observed. CAT, GPx activities (Figures 3-D and E)
and their mRNA levels (Figures 4-B and C) were significantly
increased in highest dose group (200 mg/kg; p,0.05). In lower
treatment groups of Apigenin (25 and 50 mg/kg), activity and
mRNA level of GST did not change as compared to control.
Activity of GST (Figure 3-F) was decreased in both the higher
treatment groups (100 and 200 mg/kg, statistically significant
only in 100 mg/kg Apigenin treatment group at p,0.05).
R e d u c t i o ni ni t sm R N Al e v e li nh i g h e rt r e a t m e n tg r o u p s
Figure 3. Level of oxidative stress parameters. (A) Lipid peroxidation level, (B) Ratio of GSSG/GSH, (C) activity of SOD, (D) activity of CAT, (E)
activity of GPx, and (F) activity of GST were estimated in liver following the administration of Apigenin at different doses (Control, 25, 50, 100 and
200 mg/kg). The asterisks indicate significance of differences (*-p,0.05; **-p,0.01; ***- p,0.001) in comparison to control.
doi:10.1371/journal.pone.0031964.g003
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(Figure 4-D).
Hsp70 expression
Hsp70 mRNA level showed a significant decrease along the
Apigenin treated groups (25 mg/kg; p,0.05 or 50 mg/kg;
p,0.01), decrease was apparent in higher treatment groups (100
and 200 mg/kg; p,0.001) as compared to control (Figure 4-E).
mRNA level of other members of Hsp70 family were also
decreased in higher treatment groups of Apigenin (100 and
200 mg/kg; Figure S4). Hsp70 protein content was decreased
significantly in 100 and 200 mg/kg Apigenin treated groups
(p,0.001) (Figures 5-A and C). A significant change in Hsp70
protein content was observed in lower treatment groups (25 mg/
Figure 4. Quantitative real time PCR analysis of stress regulated genes. (A) SOD1, (B) CAT, (C) GPx1, (D) GSTA4, and (E) Hsc70 mRNA levels in
the liver of mice treated with different doses of Apigenin (Control, 25, 50, 100 and 200 mg/kg). The asterisks indicate significance of differences (*-
p,0.05; **-p,0.01; ***-p,0.001) in comparison to control.
doi:10.1371/journal.pone.0031964.g004
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control.
Liver histology
Well distributed normal hepatocytes with central vein, bile duct
and hepatic artery were observed in 25 and 50 mg/kg groups. In
100 mg/kg dose group hydropic changes were observed, these
changes were eminent with ballooning and degeneration of
hepatocytes in 200 mg/kg dosed animals (Figures 6 A–E).
Differential gene expression and pathway identification
48 differentially expressed genes (36 up-regulated and 12 down-
regulated; Table 2) were identified. Among them few genes have
not been assigned any biological function, so far. Real time PCR
analysis of selected genes (Table 1 and Table S1) showed the
similar trend as found in microarray results. K-mean and
hierarchical clustering identified the similar pattern of expression
in genes at different dose levels (Figure 7). Major pathways that
showed Apigenin induced perturbations include oxidative stress,
apoptosis, inflammatory and MAP Kinase related pathways.
Microarray data analysis with MAPPFinder revealed the genes
involved in enzyme activities, cell proliferation, metabolic
processes, cell structure and signal transduction related pathways
were most affected with increased significant Z score (Z score.2)
(Table 3 and Table S3).
Discussion
Apigenin at doses of 25, 50, 100 and 200 mg/kg were evaluated
following acute exposure through intraperitoneal route to
understand the dose dependent effects in Swiss mice. Intraperi-
toneal route of exposure enables the maximum bioavailability of
Apigenin in liver. Doses of Apigenin were equivalent to the human
exposure of flavones [20] based on the equivalent body surface
area index [21]. Male Swiss mice were used in the present study to
avoid any sex dependent variations in toxic effects in female mice
due to the estrogenic action of Apigenin [22].
Unaltered serum ALT, AST and ALP in 25 or 50 mg/kg
Apigenin doses indicate its non toxic effect at these doses.
Significantly increased serum ALT, AST and ALP in 100 and
200 mg/kg Apigenin treated groups indicate the insults to liver as
increased ALT, AST and ALP in serum are typical indicators of
damaged liver [23]. Galati et al. [24] also reported 4-fold increased
Figure 5. Western blot analysis of SOD1 and Hsp70. (A) Western blots of SOD1, Hsp70 and Actin genes. Relative band intensity value of (B)
SOD1, and (C) Hsp70 after normalization with Actin. The asterisks indicate significance of differences (*-p,0.05; **-p,0.01; ***-p,0.001) in
comparison to control.
doi:10.1371/journal.pone.0031964.g005
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kg Apigenin treated groups. Slight hydropic changes and degeneration of cytoplasm within hepatocytes were observed in (D) 100 mg/kg, and (E)
200 mg/kg Apigenin treated groups respectively. Arrows indicated the degenerated hepatocytes in 200 mg/kg Apigenin treated group.
doi:10.1371/journal.pone.0031964.g006
Table 2. List of differentially expressed genes identified at p,0.05 and two fold change.
Gene Unigene ID Function Regulation P value Log value Std dev
#
Neo1 Mm.42249 ATP binding, cadherin binding Up 0.015 1.185 0.995
Bnip3l Mm.29820 Positive regulator of apoptosis, integral to membrane Up 0.027 1.180 1.123
Prpsap1 Mm.25125 Extracellular space, nucleotide biosynthesis Up 0.013 1.099 0.901
Eif5b Mm.260943 GTP binding, transferase activity, translation initiation factor activity Up 0.006 1.247 0.881
Polr2h Mm.288730 DNA-directed RNA polymerase I complex, core complex Up 0.013 1.096 0.899
Zfp110 Mm.292297 DNA binding, receptor activity Up 0.034 1.373 1.374
Idh3a Mm.279195 Oxidoreductase activity Down 0.016 21.052 0.892
Ltbp1 Mm.269747 Calcium ion binding Down 0.017 21.566 1.349
Clca1 Mm.275745 Integral to plasma membrane Down 0.035 21.053 1.060
Pank2 Mm.101264 Pantothenate kinase activity Down 0.042 21.067 1.122
Duox1 Mm.108582 Calcium ion binding, electron carrier activity Down 0.001 21.084 0.579
Pkmyt1 Mm.182193 Protein amino acid phosphorylation Down 0.013 21.035 0.844
#Standard deviation.
Note: Complete list of differentially expressed genes at p,0.05 and two fold change is given in Table S2.
doi:10.1371/journal.pone.0031964.t002
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31964plasma ALT in CD-1 mice following 24 hrs of intraperitoneal
injection of flavonoids like EGCG, propyl gallate, gallic acid and
tannic acid. Normal liver histoarchitecture of 25 or 50 mg/kg
Apigenin treated animals supports the serum findings and
suggestive of non toxic effects at these doses. Hydropic changes
along with ballooning and degeneration of hepatocytes in 100 and
200 mg/kg Apigenin treated groups are the signs of adverse effects
on mouse liver. Five fold increased ROS level in PBMCs may be
causative of damaged liver in 100 and 200 mg/kg Apigenin
treated animals as ROS damages essential biological molecules
like proteins, DNA and lipids. Previous studies also demonstrated
ROS production by Apigenin [8,9].
LPO is initiated by the attack of free radicals on fatty acid or fatty
acyl side chain of any chemical entity and is regarded as one of the
basic mechanism of tissue damage [25]. The increase of LPO level
in Apigenin treated mice at 100 and 200 mg/kg indicates free
radical generation showing the pro-oxidant nature of Apigenin.
Similar nature of Apigenin is also demonstrated in the presence of
high iron concentration in rat hepatocytes [26]. Decreased GSH
and increased ratio of GSSG and GSH in mice liver further
supports this view. Similar observations were made by Kachadour-
ianand Day[27] inPC3cells following Apigenin treatment. GSH is
the functional anti-oxidative system in physiological conditions; its
depletion might be due to its direct involvement in scavenging ROS
in the process of neutralization and subsequent protection of
essential thiol groups from oxidation. ROS are scavenged by
cellular antioxidant defence system which includes intracellular
enzymes such as SOD, CAT, GPx and GST. SOD activity and
expression was decreased significantly following 100 and 200 mg/
kg Apigenin doses. As SOD dismutates superoxide into oxygen and
H2O2 provides an important antioxidant defence in cells exposed to
oxygen, its decrease infers excessive ROS generation. Significantly
increased CAT activity in 200 mg/kg Apigenin treated mice clearly
indicates H2O2 generation. Unaltered CAT in mice at 100 mg/kg
dose may be due to more turnover of CAT in cells following
Apigenin exposure. CAT is solely responsible for the destruction of
H2O2 while GPx has a wide spectrum of activity and reduces lipid
peroxides. In the lower dose groups (25 and 50 mg/kg) CAT and
GPx activities and mRNA level were not increased which might be
due to insufficient ROS production in mice liver. GPx level was
significantly increased in 200 mg/kg Apigenin treated mice which
might be the result of decrease in GSH content. Decreased GST at
Table 3. List of most affected Gene Ontology (GO) terms (Z score.2).
Gene Ontology ID Gene Ontology name Z score Permute P
Probes involved in biological processes
22008 Neurogenesis 2.916 0.007
9987 Cellular process 2.601 0.012
6412 Translation 2.399 0.014
43170 Macromolecule metabolic process 2.263 0.014
7067 Mitosis 2.366 0.019
9888 Tissue development 2.366 0.020
904 Cellular morphogenesis during differentiation 2.410 0.026
45045 Secretory pathway 2.366 0.026
87 M phase of mitotic cell cycle 2.288 0.027
Probes involved in molecular functions
4930 G-protein coupled receptor activity 2.410 0.015
30528 Transcription regulator activity 2.431 0.018
16887 ATPase activity 2.203 0.019
3713 Transcription coactivator activity 2.521 0.022
17111 Nucleoside-triphosphatase activity 2.372 0.022
30246 Carbohydrate binding 2.512 0.023
3712 Transcription cofactor activity 2.130 0.023
16817 Hydrolase activity\, acting on acid anhydrides 2.367 0.025
5529 Sugar binding 2.591 0.033
Probes involved in cellular components
5788 Endoplasmic reticulum lumen 9.883 0.014
30529 Ribonucleoprotein complex 2.743 0.006
5829 Cytosol 2.680 0.012
5746 Mitochondrial respiratory chain 2.950 0.028
Note: Complete list of most affected Gene Ontology (GO) terms (Z score.2) is given in Table S3.
doi:10.1371/journal.pone.0031964.t003
Figure 7. Cluster analysis of differentially expressed genes. K-mean and hierarchical clustering identified the similar pattern of expression in
different dose groups of Apigenin (25, 50, 100 mg/kg). In heat map, intensities of red and green colours were proportional to relative gene induction
and repression, respectively.
doi:10.1371/journal.pone.0031964.g007
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the findings of Sahu and Gray [28] who reported the flavonoid
induced concentration-dependent decrease in GST activity. GST
protects cells against toxicants by conjugating them to GSH,
thereby neutralizing their electrophilic sites, and increases their
solubility in aiding excretion from cells [16]. The decrease in GST
along with SOD indicates severe insult to liver tissue following acute
exposure of Apigenin at higher doses. Increase in GSSG and GSH
ratio further indicated a shift of biological system towards the state
of apoptosis or necrosis. Dose-dependent reduction in Hsp70
mRNA and protein was observed following Apigenin treatment.
Hsp70 is a multigene family and it is expressed in different isoforms
in which Hsc70/Hspa8 is constitutively expressed [29]. Hsp70 is
involved in the regulation of cell proliferation, differentiation and
can be induced by heat stress, hypoxia, metals or amino acid
analogs exposure [29]. Previous studies revealed that Hsp synthesis
is blocked following the treatment of other flavonoid such as
Quercetin [30,31]. Dose related decrease in Hsp70 expression
indicates the involvement of heat shock and stress pathway that
leads towards apoptosis [32].
Gene expression data provides insight into the ongoing molecular
activities inside the cells especially in short term acute toxicity studies
where the full phenotypic signs and symptoms may have not been
fully developed [18]. In the present study, 48 differentially regulated
genes were identified that are involved in important biological
functions. Most of them (Bnip3l, Neo1, Clca1, Idh3a, Pank2, Prpsap1,
Eif5B, Polr2h, Zfp110) are engaged in regulation of apoptosis, stress
and cellgrowth.Isocitrate dehydrogenase (Idh3a) protects cellagainst
oxidative damage [33] has been shown to be more active in
producing Nicotinamide Adenine Dinucleotide Phosphate Reduced
(NADPH) than other enzymes in the previous studies [34]. Down
regulation of this gene clearly indicated that cell might have
undergone oxidative stress following Apigenin treatment. Interest-
ingly, the simultaneous upregulation of BCL2/adenovirus E1B
interacting protein 3-like (Bnip3l) [35], and Neogenin (Neo1) [36]
genes that are reported to regulate apoptosis, might be involved in
the induction of apoptosis in degenerated hepatocytes of Apigenin
treated mice in higher dose groups. Apigenin is reported to induce
apoptosis by activating different genes like PKC-d and caspases [2].
Apigenin upregulates the expression of genes involved in transcrip-
tion and translation machinery; Phosphoribosyl pyrophosphate
synthetase associated protein 1 (Prpsap1), Eukaryotic translation
initiation factor 5B (Eif5B), DNA directed polymerase (Polr2h), Zinc
finger protein 110 (Zfp110). Pantothenate kinase 2 (Pank2), a
mitochondrial enzyme catalyses the first regulatory step of
Coenzyme A synthesis, is found to be down regulated in present
study. This gene is responsible for a genetic movement disorder
named Pank-associated neurodegeneration. Recent evidences sug-
gest the silencing of Pank2 gene is directly associated with cell growth
reduction and iron deregulation in hepatic cell lines [37]. Another
downregulated gene was calcium-activated chloride channel (Clca1)
which is integrated to plasma membrane. Another downregulated
gene was calcium-activated chloride channel (Clca1) which is
integrated to plasma membrane. Differential regulation of Clca1 in
normal, apoptotic and transformed mouse cells suggested its
proapoptotic and antineoplastic nature [38]. Apigenin appears to
affect the calcium ion homeostasis by modulating the expression of
calciumionbindingproteins(Latenttransforminggrowthfactorbeta
binding protein; Ltbp1 and Dual oxidase 1; Duox1). Further analysis
of datasets on MAPPFinder identified GO terms (Z score.2)
corresponding to various biological processes, molecular functions
and cellular components. This provides evidences of significant
change in gene expression following oxidative stress associated
hepatotoxicity. Few identified genes have not been assigned any
cellular functions that might be playing important role in Apigenin
induced perturbations in mice liver.
Results indicate that Apigenin induces oxidative stress through
different pathways ensuing liver toxicity. However, further studies
are required to elucidate the detail molecular pathways of
Apigenin action.
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